Semi-Annual Statement Of Cash Flows

Fuso Pharmaceutical Industries,Ltd. - Filing #7710547

Concept As at
2019-03-31
2018-04-01 to
2019-03-31
As at
2018-03-31
2017-04-01 to
2018-03-31
As at
2017-03-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
1,255,000,000 JPY
1,361,000,000 JPY
Depreciation
1,967,000,000 JPY
1,921,000,000 JPY
Interest and dividend income
-92,000,000 JPY
-86,000,000 JPY
Interest expenses
226,000,000 JPY
220,000,000 JPY
Increase (decrease) in provision for retirement benefits
-153,000,000 JPY
-54,000,000 JPY
Increase (decrease) in provision for bonuses
-19,000,000 JPY
-19,000,000 JPY
Decrease (increase) in trade receivables
-84,000,000 JPY
-620,000,000 JPY
Decrease (increase) in inventories
-654,000,000 JPY
96,000,000 JPY
Increase (decrease) in trade payables
416,000,000 JPY
-529,000,000 JPY
Other, net
-305,000,000 JPY
438,000,000 JPY
Subtotal
2,536,000,000 JPY
2,136,000,000 JPY
Interest and dividends received
92,000,000 JPY
86,000,000 JPY
Interest paid
-229,000,000 JPY
-217,000,000 JPY
Income taxes paid
-348,000,000 JPY
-584,000,000 JPY
Net cash provided by (used in) operating activities
2,051,000,000 JPY
1,420,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-2,296,000,000 JPY
-961,000,000 JPY
Proceeds from sale of property, plant and equipment
0 JPY
743,000,000 JPY
Purchase of investment securities
-70,000,000 JPY
JPY
Proceeds from sale of investment securities
0 JPY
73,000,000 JPY
Other, net
-74,000,000 JPY
-166,000,000 JPY
Net cash provided by (used in) investing activities
-2,369,000,000 JPY
-984,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
4,900,000,000 JPY
4,600,000,000 JPY
Redemption of bonds
-38,000,000 JPY
-76,000,000 JPY
Repayments of long-term borrowings
-3,871,000,000 JPY
-3,456,000,000 JPY
Purchase of treasury shares
-6,000,000 JPY
-427,000,000 JPY
Dividends paid
-700,000,000 JPY
-706,000,000 JPY
Net cash provided by (used in) financing activities
-313,000,000 JPY
69,000,000 JPY
Other, net
-13,000,000 JPY
JPY
Net increase (decrease) in cash and cash equivalents
-630,000,000 JPY
506,000,000 JPY
Cash and cash equivalents
4,826,000,000 JPY
5,457,000,000 JPY
4,951,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.